← Open Payments lookup

RIZALINA ALBANO: Open Payments

NPI 1811430820 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$314 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $149 · 2025 $314

Food & beverage: $314
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$204
E.R. Squibb & Sons, L.L.C.2$60
ABBVIE INC.1$20
Teva Pharmaceuticals USA, Inc.1$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: INGREZZA, COBENFY, VRAYLAR, AUSTEDO XR, CAPLYTA.

Industry payments across CA — which companies pay providers there.